Particulars (Rupees in Crores.) | Mar-2025 | Sept-2024 | Mar-2024 | Sept-2023 | Mar-2023 |
---|---|---|---|---|---|
Gross Sales | 307.22 | 292.3 | 284.9 | 290.75 | 258.75 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 307.22 | 292.3 | 284.9 | 290.75 | 258.75 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 0.92 | 2.58 | 27.17 | 1.37 | -1.8 |
Total Income | 308.13 | 294.87 | 312.08 | 292.12 | 256.95 |
Total Expenditure | 261.88 | 261.32 | 245.59 | 260.06 | 238.73 |
PBIDT | 46.25 | 33.56 | 66.48 | 32.06 | 18.22 |
Interest | 19.21 | 17.74 | 15.72 | 13.46 | 14.15 |
PBDT | 27.04 | 15.82 | 50.76 | 18.6 | 4.07 |
Depreciation | 6.7 | 6.61 | 6.6 | 6.43 | 6.2 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 5.86 | 0 | 0 | 0 | 0 |
Deferred Tax | -6.99 | 0.15 | 0.26 | 0.13 | 0.14 |
Reported Profit After Tax | 21.47 | 9.06 | 43.91 | 12.05 | -2.26 |
Minority Interest After NP | 0 | 0 | 0 | 0 | 0 |
Net Profit after Minority Interest | 21.47 | 9.06 | 43.91 | 12.05 | -2.26 |
Extra-ordinary Items | 0 | 0 | 25.56 | 0 | -0.59 |
Adjusted Profit After Extra-ordinary item | 21.47 | 9.06 | 18.35 | 12.05 | -1.67 |
EPS (Unit Curr.) | 6.55 | 2.76 | 13.41 | 3.68 | 0 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 0 | 0 |
Equity | 32.77 | 32.76 | 32.75 | 32.74 | 32.71 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 15.05 | 11.48 | 23.33 | 11.02 | 7.04 |
PBDTM(%) | - | - | - | - | - |
PATM(%) | 6.98 | 3.09 | 15.41 | 4.14 | -0.87 |
The ANVISA certificate will be valid until May 12, 2027, provided that the applicable GMPs continue to be observed.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.